To evaluate the contribution in terms of information provision and patients* perspectives of ICU-VR to prepare lung transplant patients for their future ICU admission
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
PTSS
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary endpoint will be the difference in information provision of the ICU
care of lung transplant patients on the waiting list.
Secondary outcome
Patients' perspectives about the ICU-VR intervention and the lung transplant
preparation process. We also measure PTSD symptoms 2 weeks after ICU admission.
Background summary
A substantial proportion of the Intensive Care Unit (ICU) survivors develop
psychological impairments due to their ICU admission. Several interventions to
mitigate these impairments have been explored but lack a proper effect.
Intensive Care Unit-specific Virtual Reality has proven to be potentially
effective in treating PTSD and depression-related sequelae in ICU-survivors.
Study objective
To evaluate the contribution in terms of information provision and patients*
perspectives of ICU-VR to prepare lung transplant patients for their future ICU
admission
Study design
A monocentre randomized controlled study.
Intervention
The ICU-VR intervention is designed by an interdisciplinary team of
intensivists, ICU nurses, a psychiatrist, a psychologist, and a former ICU
patient, to expose patients to the ICU environment while offering treatment-
and department-related information. During the 12-minute lasting intervention,
patients experience different facets of ICU treatment and receive information
on the ICU environment, treatment and workflow. The intervention group will
receive this treatment as many times as desired, as part of the study outcomes,
during the appointment with the lung transplantation nurse. The placebo group
will receive standard care and no additional intervention.
Study burden and risks
The safety and immersiveness of the ICU-VR module was previously examined in
healthy volunteers. ICU-VR did not lead to clinically relevant symptoms of
cybersickness or to changes in vital signs and VR resulted in high immersion
scores. The feasibility, safety, and effect were tested in a pilot study in
sepsis survivors. There were no safety concerns, the intervention was feasible,
and may improve psychological impairments following critical illness. The
questionnaires will take approximately 15-20 minutes to fill in. No risks are
expected for participating patients. Participants in the intervention group
will have to visit the hospital once to undergo the VR session, this will be
combined with other hospital appointments as much as possible to minimize the
time burden for participants.
Potential benefits of the study are a better understanding of the ICU
environment, workflow, and treatment, a reduction in PTSD after ICU discharge,
and an increased satisfaction with the preparation and aftercare of the ICU.
Dr. Molewaterplein 40
Rotterdam 3015GD
NL
Dr. Molewaterplein 40
Rotterdam 3015GD
NL
Listed location countries
Age
Inclusion criteria
On the waiting list for lung transplantation
Able to understand en read the Dutch language
Exclusion criteria
Epilepsy
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| ClinicalTrials.gov | NCT06642636 |
| CCMO | NL87675.078.24 |